Advice for biotech, grounded in the biology.
Trained at the bench, tested on Wall Street. SZS BioAdvisors helps biotech companies and their boards with partnering, licensing and strategy, and we read the science with the same care as the deal terms.
- What we do
- Out-licensing, partnering, and sell-side processes
- Scientific and competitive diligence and landscaping
- Pipeline and corporate strategy
- Core focus
- Oncology, rare disease, neuroscience and radiopharmaceuticals
- Background
- An Ivy League PhD scientist turned Wall Street equity research analyst, then healthcare investment banker. Deep experience across biotherapeutics and pharma, from mechanism of action to deal structure.